[ad_1]
OpenAI calls its offering “temporary” and for a select group of users before the company builds the “best” features into ChatGPT.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...